Services

Market Access & Commercial Strategy

Aligning clinical, evidence, and commercial planning for a successful launch

Opportunity Assessment
Market Access & Payer Strategy
Value Proposition
Pricing Estimates & Forecast Scenarios
Market Sizing & Segmentation
Competitive Landscape Analysis
Advisory Boards & KOL/Payer Interviews
Target Product Profile Optimization
Indication & Launch Sequencing
Go-to-Market Strategy
Simulations & Risk Assessment
Why Innopiphany

Women- and minority-owned — delivering market access & commercial strategy since 2015.

As one of the only women- and minority-owned small businesses working in this space, Innopiphany pairs deep commercial expertise with unique experience supporting early-stage assets.

0
Market forecasts
0
Market opportunity assessments
0
Indication sequencing evaluations
0
Early-stage assets evaluated (pre-/Phase I/II)
Core competencies

Access to a vast network

Innopiphany draws on deep, direct relationships across the healthcare ecosystem.

Providers

Policy Makers

Payers

Patient Advocacy Groups

Patients

Qualitative and quantitative research, amplified and analyzed through advanced data analytics — to glean insights on a diverse range of topics:

Policy Issues
Market Research & Access
Social Drivers of Health
How we work

Systematic methodologies and analytical tools

Innopiphany applies systematic methodologies combined with analytical tools throughout market research.

Value Assessment
  • Value proposition
  • Early use-case / treatment-paradigm assessments
  • Stakeholder identification
  • Market-fit analysis
Market Sizing & Segmentation
  • Secondary research (epidemiology, clinical trials, literature search)
  • Primary research (KOLs, providers, payers, patients, patient advocates) — interviews, surveys & focus groups
  • Competitive landscape
Pricing Estimates & Forecast Scenarios
  • Historical analogs
  • Delphi panels
  • Conjoint / discrete-choice
  • Regression analyses
  • Budget-impact models
  • Pricing & reimbursement
  • NPV/IRR, COGS, R&D costs, and SGR
Simulations & Risk Assessment
  • Monte Carlo analysis
  • Probability of Technical and Regulatory Success (PTRS)
  • Indication & launch sequencing
  • Cost-effectiveness analysis (decision trees, Markov models, and hybrid models)
← All services Get in touch